SLC31A1 and lung carcinoma: These observations not only support the function mode of rs10759637 on SLC31A1 expression, but also provide comparative and evolutionary pharmacogenetics implications for the association of SLC31A1 polymorphism with clinical outcomes of platinum-based chemotherapy in lung cancer.